Jonathan P. Mow
2021
In 2021, Jonathan P. Mow earned a total compensation of $1.5M as Chief Executive Officer at PhaseBio Pharmaceuticals, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $318,519 |
|---|---|
| Option Awards | $634,444 |
| Salary | $561,933 |
| Other | $14,212 |
| Total | $1,529,108 |
Mow received $634.4K in option awards, accounting for 41% of the total pay in 2021.
Mow also received $318.5K in non-equity incentive plan, $561.9K in salary and $14.2K in other compensation.
Rankings
In 2021, Jonathan P. Mow's compensation ranked 7,167th out of 12,412 executives tracked by ExecPay. In other words, Mow earned more than 42.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,167 out of 12,412 | 42nd |
Division Manufacturing | 3,137 out of 5,498 | 43rd |
Major group Chemicals And Allied Products | 1,387 out of 2,374 | 42nd |
Industry group Drugs | 1,234 out of 2,095 | 41st |
Industry Pharmaceutical Preparations | 903 out of 1,542 | 41st |
Source: SEC filing on April 22, 2022.
Mow's colleagues
We found two more compensation records of executives who worked with Jonathan P. Mow at PhaseBio Pharmaceuticals in 2021.